Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank67
3Y CAGR+29.4%
5Y CAGR+266.9%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+29.4%/yr
Annual compound
5Y CAGR
+266.9%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
664.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$9.30M-32.6%
2024$13.81M-14.5%
2023$16.16M+276.5%
2022$4.29M+11819.4%
2021$36000.00+157.1%
2020$14000.00-92.0%
2019$176000.00-